Moya-Guzmán MJ, González-Mienert E, Pinto C, and Pino-Lagos K. ImmunoHorizons, 2026.

This study investigates the role of Neuropilin-1 (Nrp1) in the differentiation and immunosuppressive activity of induced regulatory T cells (iTregs), with particular emphasis on the function of small extracellular vesicles (sEVs) released by these cells. Tregs are essential for maintaining immune tolerance and limiting excessive immune responses, and their suppressive mechanisms include the release of sEVs containing regulatory molecules. Previous studies had established that natural Treg (nTreg)-derived sEVs contain Nrp1 and that this molecule contributes to their immunosuppressive function. The present study extends these observations to TGF-β-induced Tregs, which are of particular interest because they may represent a more abundant source for potential cell-based or extracellular-vesicle-based therapies.

The authors used wild-type (WT) mice and mice with a conditional deletion of Nrp1 in FoxP3+ cells. Splenic CD4+CD25− T cells were cultured with IL-2 and TGF-β under polyclonal stimulation to induce their differentiation into iTregs. After five days, the phenotype of these cells was analyzed by flow cytometry, while sEVs were isolated from culture supernatants through differential ultracentrifugation followed by size-exclusion purification. Vesicles were characterized using nanoparticle tracking analysis and Western blotting. Their immunomodulatory activity was subsequently tested by exposing activated CD4+ T cells to sEVs derived from either WT or Nrp1KO iTregs and assessing proliferation, phenotype, and cytokine production.

One of the study’s first major findings was that Nrp1 is important for optimal iTreg differentiation. After five days under Treg-inducing conditions, approximately 95% of WT CD4+ T cells expressed FoxP3, compared with only about 55% of cells from Nrp1KO mice. CD25 and CD73 were highly expressed in both groups, whereas Nrp1 expression was, as expected, substantially reduced in Nrp1KO cells. These findings indicate that Nrp1 contributes to the de novo induction or maintenance of FoxP3 expression during TGF-β-driven differentiation of conventional CD4+ T cells into iTregs.

The study further demonstrated that Nrp1 is not necessary for sEV production itself. WT and Nrp1KO iTregs produced vesicles with similar average sizes and size distributions, with approximately 90% falling within the 51–250 nm range. Surprisingly, however, Nrp1KO iTregs released approximately twice as many particles as WT iTregs. Nrp1 was detected in sEVs derived from WT iTregs but was nearly absent from Nrp1KO-derived vesicles. These observations suggest that although Nrp1 is not required for vesicle release, it may participate in the regulation of sEV biogenesis, trafficking, recycling, or degradation.

The most important functional result concerns the suppression of CD4+ T-cell proliferation. When activated CD4+ T cells were cultured with sEVs from WT iTregs, proliferation decreased from approximately 100% in control cultures to around 60%. By contrast, sEVs produced by Nrp1KO iTregs largely failed to suppress proliferation. The authors therefore conclude that Nrp1 is required for the antiproliferative activity mediated by iTreg-derived sEVs. Figure 3 illustrates this effect and shows an average suppressive activity of approximately 35% for WT-derived sEVs, despite considerable variability among individual vesicle batches.

The vesicles also altered the phenotype of recipient CD4+ T cells. WT iTreg-derived sEVs increased the proportion of FoxP3+ cells and produced a decrease in CD25 expression together with an increase in CD44 and CD73. Importantly, the ability of individual sEV preparations to induce FoxP3 positively correlated with their suppressive activity. Most of these changes were lost when vesicles originated from Nrp1KO iTregs: Nrp1-deficient sEVs failed to efficiently induce FoxP3 and did not reproduce the changes in CD25 and CD73 observed with WT vesicles. CD44 represented an exception, as its expression increased after exposure to both WT and Nrp1KO sEVs, suggesting an Nrp1-independent mechanism.

These phenotypic changes suggest that WT iTreg-derived sEVs can shift activated conventional CD4+ T cells toward a more immunoregulatory phenotype. Reduced CD25 expression in FoxP3− cells may limit their capacity to respond to IL-2 and consequently restrict proliferation. Meanwhile, increased CD73 expression is potentially relevant because CD73 generates extracellular adenosine, a molecule with well-established immunosuppressive effects. The authors also propose that increased Nrp1 expression in recipient CD4+ T cells could enhance their responsiveness to TGF-β and thereby influence FoxP3 expression, activation, and proliferation.

Interestingly, not every immunomodulatory effect of iTreg-derived sEVs depended on Nrp1. Both WT and Nrp1KO sEVs reduced IL-10 production, and both produced a reduction in IFN-γ, although the latter did not reach statistical significance. Neither WT nor Nrp1KO sEVs produced a statistically significant effect on IL-17A. Thus, while Nrp1 is critical for controlling CD4+ T-cell proliferation and several phenotypic changes, regulation of IL-10 and possibly IFN-γ secretion appears to occur through Nrp1-independent components of the vesicles.

Mechanistically, the authors propose that Nrp1 may influence both TGF-β signaling and extracellular-vesicle function. Since TGF-β induces FoxP3 through pathways involving SMAD3 and STAT5, the reduced FoxP3 induction observed in Nrp1-deficient cells could result from impaired TGF-β signaling. Previous evidence showing that Nrp1 affects SMAD3 phosphorylation supports this possibility. The unexpected increase in sEV production by Nrp1KO iTregs also raises the possibility that Nrp1 participates in vesicle biogenesis or trafficking.

The precise reason why the absence of Nrp1 causes an almost complete loss of sEV-mediated suppression remains unresolved. The authors propose two main explanations. First, deletion of Nrp1 may alter the molecular cargo of sEVs, meaning that Nrp1KO vesicles may lack other molecules necessary for immunosuppression. Second, Nrp1 itself may have a direct functional role on the vesicle surface by facilitating interaction, recruitment, fusion, or endocytosis by recipient cells. In this model, Nrp1 would help deliver the vesicle’s bioactive cargo to target CD4+ T cells, and its absence would compromise this process.

The authors acknowledge several limitations and unresolved questions. The specific CD4+ T-cell subsets responsible for cytokine production were not identified through intracellular cytokine staining, and some findings—particularly those involving IFN-γ and IL-17A—did not reach statistical significance. Furthermore, substantial variability was observed among different sEV preparations. Future experiments proposed by the authors include blocking Nrp1 directly on WT-derived sEVs with anti-Nrp1 antibodies to determine whether suppression is lost, as well as examining the effects of sEV-modulated CD4+ T cells on other immune-cell populations.

Overall significance

Overall, the study demonstrates that TGF-β-induced Tregs produce biologically active small extracellular vesicles capable of suppressing CD4+ T-cell proliferation and modifying their phenotype, and that several of these effects critically depend on Nrp1. Nrp1 appears to have a dual role: it contributes to the efficient differentiation of CD4+ T cells into FoxP3+ iTregs and is required for the suppressive activity of the sEVs subsequently released by these cells.

The findings therefore expand the known immunoregulatory role of Nrp1 beyond natural Tregs and establish iTreg-derived sEVs as potential cell-free immunomodulatory agents. From a translational perspective, however, the considerable batch-to-batch variability in suppressive activity indicates that standardized methods for sEV production, purification, characterization, and functional testing will be necessary. The authors propose that the capacity of a given sEV preparation to induce FoxP3 expression in conventional CD4+ T cells could potentially serve as a functional indicator of its immunosuppressive potency.